Covid-19 caused supply chain issues across the world, but Triangle biotech companies say their teams were able to pivot quickly and dodge any major setbacks. Drug manufacturing has been slowly migrating out of the U.S. for several decades. For instance, just 28 percent of the manufacturing….Read MoreSecurity News